Injective (INJ) gains momentum with a 15% price surge, driven by its EVM testnet launch, soaring on-chain activity, and strategic partnerships with Google Cloud and Deutsche Telekom.
Injective (INJ) Surges 15% Amid EVM Testnet Launch and Strategic Partnerships
3 weeks ago Injective (INJ) gains momentum with a 15% price surge, driven by its EVM testnet launch, soaring on-chain activity, and strategic partnerships with Google Cloud and Deutsche Telekom.
Related
That's Just Investing And Life!
1 hour ago
